One-Year Comparative Outcomes of Conventional Versus Accelerated Corneal Cross-Linking in Progressive Keratoconus
Abstract
Background and Objectives: Corneal collagen cross-linking (CXL) halts keratoconus progression, yet potential differences between conventional and accelerated protocols at one year remain uncertain. We analyzed the completed 12-month follow-up of a previously reported 6-month cohort to compare conventional (3 mW/cm2 × 30 min; CXL 30) versus accelerated (9 mW/cm2 × 10 min; CXL 10) CXL, interpreting outcomes within the ABCD framework alongside Kmax and curvature radii. Materials and Methods: In this single-center retrospective longitudinal analysis of prospectively collected routine clinical data, 22 eyes were included, with assessments performed at baseline and at 1, 3, 6, and 12 months of follow-up. Evaluated outcomes comprised ABCD stages (A-D), anterior and posterior radius of curvature (ARC and PRC), Kmax, pachymetric and elevation indices, as well as UDVA and BCVA. Within-group change used Friedman with Wilcoxon post hoc; between-group differences used Mann-Whitney (α = 0.05). Results: Both protocols resulted in significant visual improvement and Kmax reduction at 12 months (overall time effect: CXL 30 p p = 0.026). Median Kmax decreased 56.5 → 52.3 D (CXL 30) and 59.3 → 58.3 D (CXL 10). UDVA improved 0.2 → 0.6 (CXL 30) and 0.2 → 0.3 (CXL 10); BCVA 0.4 → 0.8 (CXL 30) and 0.2 → 0.5 (CXL 10). Tomographic analysis showed predominantly anterior changes, with a significant decrease in A stage in the CXL 30 group and an increase in ARC in both groups, more pronounced in CXL 30.…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence.
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.